Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography

Identifieur interne : 001B55 ( PascalFrancis/Corpus ); précédent : 001B54; suivant : 001B56

Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography

Auteurs : Blagoj Mitrevski ; Biljana Veleska ; Erwan Engel ; Paul Wynne ; SHIN MIIN SONG ; Philip J. Marriott

Source :

RBID : Pascal:11-0300963

Descripteurs français

English descriptors

Abstract

A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (2D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the 2D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0379-0738
A02 01      @0 FSINDR
A03   1    @0 Forensic sci. int.
A05       @2 209
A06       @2 1-3
A08 01  1  ENG  @1 Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography
A11 01  1    @1 MITREVSKI (Blagoj)
A11 02  1    @1 VELESKA (Biljana)
A11 03  1    @1 ENGEL (Erwan)
A11 04  1    @1 WYNNE (Paul)
A11 05  1    @1 SHIN MIIN SONG
A11 06  1    @1 MARRIOTT (Philip J.)
A14 01      @1 Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V @2 Melbourne, Victoria 3001 @3 AUS @Z 1 aut. @Z 3 aut. @Z 6 aut.
A14 02      @1 Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb @2 1000 Skopje @3 MKD @Z 2 aut.
A14 03      @1 INRA, UR370 QuaPA @2 63122 Saint-Genes-Champanelle @3 FRA @Z 3 aut.
A14 04      @1 SGE Analytical Science Ltd., 7 Argent Place @2 Ringwood, Victoria 3134 @3 AUS @Z 4 aut.
A14 05      @1 Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road @2 Singapore 117685 @3 SGP @Z 5 aut.
A20       @1 11-20
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 15440 @5 354000190377130020
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 42 ref.
A47 01  1    @0 11-0300963
A60       @1 P
A61       @0 A
A64 01  1    @0 Forensic science international
A66 01      @0 GBR
C01 01    ENG  @0 A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (2D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the 2D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.
C02 01  X    @0 002B24
C02 02  X    @0 002B30A10
C02 03  X    @0 002B01
C03 01  X  FRE  @0 Amphétamine(N-méthyl-3,4-méthylènedioxy) @2 FX @5 01
C03 02  X  FRE  @0 Substance toxicomanogène @5 02
C03 02  X  ENG  @0 Drug of abuse @5 02
C03 02  X  SPA  @0 Sustancia toxicomanógena @5 02
C03 03  X  FRE  @0 Impureté @5 03
C03 03  X  ENG  @0 Impurity @5 03
C03 03  X  SPA  @0 Impureza @5 03
C03 04  X  FRE  @0 Chromatographie phase gazeuse @5 04
C03 04  X  ENG  @0 Gas chromatography @5 04
C03 04  X  SPA  @0 Cromatografía fase gaseosa @5 04
C03 05  X  FRE  @0 Criminalistique @5 05
C03 05  X  ENG  @0 Criminalistics @5 05
C03 05  X  SPA  @0 Criminalistica @5 05
C03 06  X  FRE  @0 Médecine légale @5 06
C03 06  X  ENG  @0 Legal medicine @5 06
C03 06  X  SPA  @0 Medicina legal @5 06
C03 07  X  FRE  @0 Aspect médicolégal @5 25
C03 07  X  ENG  @0 Forensic aspect @5 25
C03 07  X  SPA  @0 Aspecto forense @5 25
C03 08  X  FRE  @0 Police scientifique @5 26
C03 08  X  ENG  @0 Forensic science @5 26
C03 08  X  SPA  @0 Ciencia forense @5 26
C03 09  X  FRE  @0 Ecstasy @4 INC @5 86
C03 10  X  FRE  @0 Profilage criminel @4 INC @5 87
C07 01  X  FRE  @0 Drogue illicite @5 37
C07 01  X  ENG  @0 Illicit drug @5 37
C07 01  X  SPA  @0 Droga ilícita @5 37
C07 02  X  FRE  @0 Drogue récréative @2 FX @5 38
C07 02  X  ENG  @0 Recreational drug @2 FX @5 38
C07 02  X  SPA  @0 Droga recreativa @2 FX @5 38
N21       @1 206
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0300963 INIST
ET : Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography
AU : MITREVSKI (Blagoj); VELESKA (Biljana); ENGEL (Erwan); WYNNE (Paul); SHIN MIIN SONG; MARRIOTT (Philip J.)
AF : Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V/Melbourne, Victoria 3001/Australie (1 aut., 3 aut., 6 aut.); Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb/1000 Skopje/Macédoine (2 aut.); INRA, UR370 QuaPA/63122 Saint-Genes-Champanelle/France (3 aut.); SGE Analytical Science Ltd., 7 Argent Place/Ringwood, Victoria 3134/Australie (4 aut.); Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road/Singapore 117685/Singapour (5 aut.)
DT : Publication en série; Niveau analytique
SO : Forensic science international; ISSN 0379-0738; Coden FSINDR; Royaume-Uni; Da. 2011; Vol. 209; No. 1-3; Pp. 11-20; Bibl. 42 ref.
LA : Anglais
EA : A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (2D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the 2D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.
CC : 002B24; 002B30A10; 002B01
FD : Amphétamine(N-méthyl-3,4-méthylènedioxy); Substance toxicomanogène; Impureté; Chromatographie phase gazeuse; Criminalistique; Médecine légale; Aspect médicolégal; Police scientifique; Ecstasy; Profilage criminel
FG : Drogue illicite; Drogue récréative
ED : Drug of abuse; Impurity; Gas chromatography; Criminalistics; Legal medicine; Forensic aspect; Forensic science
EG : Illicit drug; Recreational drug
SD : Sustancia toxicomanógena; Impureza; Cromatografía fase gaseosa; Criminalistica; Medicina legal; Aspecto forense; Ciencia forense
LO : INIST-15440.354000190377130020
ID : 11-0300963

Links to Exploration step

Pascal:11-0300963

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography</title>
<author>
<name sortKey="Mitrevski, Blagoj" sort="Mitrevski, Blagoj" uniqKey="Mitrevski B" first="Blagoj" last="Mitrevski">Blagoj Mitrevski</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Veleska, Biljana" sort="Veleska, Biljana" uniqKey="Veleska B" first="Biljana" last="Veleska">Biljana Veleska</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb</s1>
<s2>1000 Skopje</s2>
<s3>MKD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Engel, Erwan" sort="Engel, Erwan" uniqKey="Engel E" first="Erwan" last="Engel">Erwan Engel</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>INRA, UR370 QuaPA</s1>
<s2>63122 Saint-Genes-Champanelle</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wynne, Paul" sort="Wynne, Paul" uniqKey="Wynne P" first="Paul" last="Wynne">Paul Wynne</name>
<affiliation>
<inist:fA14 i1="04">
<s1>SGE Analytical Science Ltd., 7 Argent Place</s1>
<s2>Ringwood, Victoria 3134</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Shin Miin Song" sort="Shin Miin Song" uniqKey="Shin Miin Song" last="Shin Miin Song">SHIN MIIN SONG</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road</s1>
<s2>Singapore 117685</s2>
<s3>SGP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Marriott, Philip J" sort="Marriott, Philip J" uniqKey="Marriott P" first="Philip J." last="Marriott">Philip J. Marriott</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0300963</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0300963 INIST</idno>
<idno type="RBID">Pascal:11-0300963</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B55</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography</title>
<author>
<name sortKey="Mitrevski, Blagoj" sort="Mitrevski, Blagoj" uniqKey="Mitrevski B" first="Blagoj" last="Mitrevski">Blagoj Mitrevski</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Veleska, Biljana" sort="Veleska, Biljana" uniqKey="Veleska B" first="Biljana" last="Veleska">Biljana Veleska</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb</s1>
<s2>1000 Skopje</s2>
<s3>MKD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Engel, Erwan" sort="Engel, Erwan" uniqKey="Engel E" first="Erwan" last="Engel">Erwan Engel</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>INRA, UR370 QuaPA</s1>
<s2>63122 Saint-Genes-Champanelle</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wynne, Paul" sort="Wynne, Paul" uniqKey="Wynne P" first="Paul" last="Wynne">Paul Wynne</name>
<affiliation>
<inist:fA14 i1="04">
<s1>SGE Analytical Science Ltd., 7 Argent Place</s1>
<s2>Ringwood, Victoria 3134</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Shin Miin Song" sort="Shin Miin Song" uniqKey="Shin Miin Song" last="Shin Miin Song">SHIN MIIN SONG</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road</s1>
<s2>Singapore 117685</s2>
<s3>SGP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Marriott, Philip J" sort="Marriott, Philip J" uniqKey="Marriott P" first="Philip J." last="Marriott">Philip J. Marriott</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Forensic science international</title>
<title level="j" type="abbreviated">Forensic sci. int.</title>
<idno type="ISSN">0379-0738</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Forensic science international</title>
<title level="j" type="abbreviated">Forensic sci. int.</title>
<idno type="ISSN">0379-0738</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Criminalistics</term>
<term>Drug of abuse</term>
<term>Forensic aspect</term>
<term>Forensic science</term>
<term>Gas chromatography</term>
<term>Impurity</term>
<term>Legal medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Amphétamine(N-méthyl-3,4-méthylènedioxy)</term>
<term>Substance toxicomanogène</term>
<term>Impureté</term>
<term>Chromatographie phase gazeuse</term>
<term>Criminalistique</term>
<term>Médecine légale</term>
<term>Aspect médicolégal</term>
<term>Police scientifique</term>
<term>Ecstasy</term>
<term>Profilage criminel</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (
<sup>2</sup>
D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the
<sup>2</sup>
D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0379-0738</s0>
</fA01>
<fA02 i1="01">
<s0>FSINDR</s0>
</fA02>
<fA03 i2="1">
<s0>Forensic sci. int.</s0>
</fA03>
<fA05>
<s2>209</s2>
</fA05>
<fA06>
<s2>1-3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MITREVSKI (Blagoj)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>VELESKA (Biljana)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ENGEL (Erwan)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>WYNNE (Paul)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>SHIN MIIN SONG</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>MARRIOTT (Philip J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V</s1>
<s2>Melbourne, Victoria 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb</s1>
<s2>1000 Skopje</s2>
<s3>MKD</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>INRA, UR370 QuaPA</s1>
<s2>63122 Saint-Genes-Champanelle</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>SGE Analytical Science Ltd., 7 Argent Place</s1>
<s2>Ringwood, Victoria 3134</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road</s1>
<s2>Singapore 117685</s2>
<s3>SGP</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20>
<s1>11-20</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>15440</s2>
<s5>354000190377130020</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>42 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0300963</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Forensic science international</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (
<sup>2</sup>
D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the
<sup>2</sup>
D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B24</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B30A10</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Amphétamine(N-méthyl-3,4-méthylènedioxy)</s0>
<s2>FX</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Substance toxicomanogène</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Drug of abuse</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Sustancia toxicomanógena</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Impureté</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Impurity</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Impureza</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Chromatographie phase gazeuse</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Gas chromatography</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Cromatografía fase gaseosa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Criminalistique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Criminalistics</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Criminalistica</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Médecine légale</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Legal medicine</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Medicina legal</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Aspect médicolégal</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Forensic aspect</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Aspecto forense</s0>
<s5>25</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Police scientifique</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Forensic science</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Ciencia forense</s0>
<s5>26</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Ecstasy</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Profilage criminel</s0>
<s4>INC</s4>
<s5>87</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Drogue illicite</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Illicit drug</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Droga ilícita</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Drogue récréative</s0>
<s2>FX</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Recreational drug</s0>
<s2>FX</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Droga recreativa</s0>
<s2>FX</s2>
<s5>38</s5>
</fC07>
<fN21>
<s1>206</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0300963 INIST</NO>
<ET>Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography</ET>
<AU>MITREVSKI (Blagoj); VELESKA (Biljana); ENGEL (Erwan); WYNNE (Paul); SHIN MIIN SONG; MARRIOTT (Philip J.)</AU>
<AF>Australian Centre for Research on Separation Science, RMIT University, GPO Box 2476V/Melbourne, Victoria 3001/Australie (1 aut., 3 aut., 6 aut.); Forensic Science Unit, Ministry of Internal Affairs, Dimce Mircev bb/1000 Skopje/Macédoine (2 aut.); INRA, UR370 QuaPA/63122 Saint-Genes-Champanelle/France (3 aut.); SGE Analytical Science Ltd., 7 Argent Place/Ringwood, Victoria 3134/Australie (4 aut.); Institute of Microelectronics, Agency for Science, Technology and Research (A*STAR), 11 Science Park Road/Singapore 117685/Singapour (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Forensic science international; ISSN 0379-0738; Coden FSINDR; Royaume-Uni; Da. 2011; Vol. 209; No. 1-3; Pp. 11-20; Bibl. 42 ref.</SO>
<LA>Anglais</LA>
<EA>A method for ecstasy volatiles 'signature' analysis based on two-dimensional gas chromatography separation and time-of-flight mass spectrometry detection (GC x GC-TOFMS) is presented. Organic impurity volatiles were extracted by head space solid phase microextraction (HS-SPME). The final column phase choice of the four different column combinations tested was a low-polarity 5% phenyl polysilphenylene-siloxane coupled with a polyethylene glycol phase, which best displayed the complex impurity profile. Second dimension (
<sup>2</sup>
D) retention time reproducibility was found to be about 1 % RSD, and area reproducibility of SPME sampling was just over 5% RSD for compounds with S/N ratio of about 100. High similarity of TOFMS spectra of impurities was obtained against commercial MS libraries. 16 components from the two-dimensional profiles were selected for comparison of the 24 ecstasy tablets, most of which proved to be benzodioxole derived compounds. All tablets were correctly classified in eight groups according to their post-tabletting characteristics, when appropriate data pre-treatment was applied. Principal component analysis revealed clustering of samples according to the country of origin. Samples from Macedonia were elevated in N-formyl-MDMA and N-acetyl-MDMA while samples from Australia were elevated in 3,4-methylenedioxypropane and 3,4-methylenedioxyacetophenone. Furthermore, three components were found to be unique for one of the source countries. The additional separation of components on the
<sup>2</sup>
D column, increased response due to modulation, high acquisition rate with full mass spectra using TOFMS detection, and MS deconvolution extend the possibility of detecting additional markers and route-specific components, especially of low abundant, polar components.</EA>
<CC>002B24; 002B30A10; 002B01</CC>
<FD>Amphétamine(N-méthyl-3,4-méthylènedioxy); Substance toxicomanogène; Impureté; Chromatographie phase gazeuse; Criminalistique; Médecine légale; Aspect médicolégal; Police scientifique; Ecstasy; Profilage criminel</FD>
<FG>Drogue illicite; Drogue récréative</FG>
<ED>Drug of abuse; Impurity; Gas chromatography; Criminalistics; Legal medicine; Forensic aspect; Forensic science</ED>
<EG>Illicit drug; Recreational drug</EG>
<SD>Sustancia toxicomanógena; Impureza; Cromatografía fase gaseosa; Criminalistica; Medicina legal; Aspecto forense; Ciencia forense</SD>
<LO>INIST-15440.354000190377130020</LO>
<ID>11-0300963</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B55 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001B55 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0300963
   |texte=   Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024